Retour
Fourchette du Jour
16,50 €
17,32 €
Fourchette 52 Semaines
5,95 €
62,75 €
Volume
774 940
Moyenne 50J / 200J
16,85 €
/
29,02 €
Clôture Précédente
16,27 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -5,3 | 0,4 |
| P/B | 4,0 | 2,9 |
| ROE % | -60,5 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
19,88 €
+17.8%
Low: 8,00 €
High: 35,00 €
BPA Prévisionnel
-3,65 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,74 €
1,74 € – 4,15 €
|
900 M | 6 |
| FY2029 |
-0,48 €
-0,72 € – -0,30 €
|
450 M | 6 |
| FY2028 |
-2,59 €
-4,77 € – -0,86 €
|
140 M | 8 |
Points Clés
Debt/Equity of 0,25 — conservative balance sheet
Negative free cash flow of -196,04M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-60,51%
ROIC-48,30%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,25
Current Ratio9,27
Interest Coverage-33,78
Valorisation
P/E Ratio
-5,32
P/B Ratio3,97
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -227,32M |
| ROE | -60,51% | ROA | -53,56% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -196,04M |
| ROIC | -48,30% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,25 | Current Ratio | 9,27 |
| Interest Coverage | -33,78 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -5,32 | P/B Ratio | 3,97 |
| P/S Ratio | N/A | PEG Ratio | -0,04 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,21B | Enterprise Value | 951,24M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -227,32M | -118,94M | -36,01M | -49,97M | -53,64M |
| EPS (Diluted) | -3,53 | -1,89 | -0,73 | -2,20 | -1,45 |
| Gross Profit | -2,62M | 0,0 | 0,0 | 0,0 | -4 971,0 |
| Operating Income | -244,83M | -143,09M | -54,12M | -65,06M | -53,58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 424,43M | 477,93M | 526,54M | 76,84M | 9,68M |
| Total Liabilities | 119,95M | 24,54M | 13,05M | 8,08M | 21,33M |
| Shareholders' Equity | 304,48M | 446,83M | 495,68M | 48,90M | -11,65M |
| Total Debt | 75,71M | 2,83M | 3,70M | 282 580,0 | 15,00M |
| Cash & Equivalents | 334,52M | 180,43M | 451,17M | 39,51M | 8,04M |
| Current Assets | 421,69M | 474,29M | 514,17M | 76,51M | 9,64M |
| Current Liabilities | 45,48M | 22,46M | 9,97M | 7,67M | 21,09M |